KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arbutus Biopharma (ABUS) Net Cash Flow: 2009-2024

Historic Net Cash Flow for Arbutus Biopharma (ABUS) over the last 16 years, with Dec 2024 value amounting to $10.1 million.

  • Arbutus Biopharma's Net Cash Flow rose 51.56% to -$15.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.4 million, marking a year-over-year decrease of 165.78%. This contributed to the annual value of $10.1 million for FY2024, which is 323.52% up from last year.
  • According to the latest figures from FY2024, Arbutus Biopharma's Net Cash Flow is $10.1 million, which was up 323.52% from -$4.5 million recorded in FY2023.
  • Arbutus Biopharma's 5-year Net Cash Flow high stood at $57.0 million for FY2021, and its period low was -$78.5 million during FY2022.
  • In the last 3 years, Arbutus Biopharma's Net Cash Flow had a median value of -$4.5 million in 2023 and averaged -$24.3 million.
  • Its Net Cash Flow has fluctuated over the past 5 years, first surged by 491.40% in 2020, then slumped by 237.63% in 2022.
  • Over the past 5 years, Arbutus Biopharma's Net Cash Flow (Yearly) stood at $20.4 million in 2020, then spiked by 179.59% to $57.0 million in 2021, then plummeted by 237.63% to -$78.5 million in 2022, then spiked by 94.25% to -$4.5 million in 2023, then spiked by 323.52% to $10.1 million in 2024.